Vascular abnormalities in human newborns with pulmonary hypertension

References

• Walsh-Sukys MC, Tyson JE, Wright LL et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics105(1 Pt 1), 14–20 (2000).
   PubMed Web of Science ®Google Scholar
• Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics117(4), 1077–1083 (2006).
   PubMed Web of Science ®Google Scholar
• Leibovitch L, Matok I, Paret G. Therapeutic applications of sildenafil citrate in the management of paediatric pulmonary hypertension. Drugs67(1), 57–73 (2007).
   PubMed Web of Science ®Google Scholar
• Mohseni-Bod H, Bohn D. Pulmonary hypertension in congenital diaphragmatic hernia. Semin. Pediatr. Surg.16(2), 126–133 (2007).
   PubMedGoogle Scholar
• Cua CL, Blankenship A, North AL, Hayes J, Nelin LD. Increased incidence of idiopathic persistent pulmonary hypertension in Down syndrome neonates. Pediatr. Cardiol.28(4), 250–254 (2007).
   PubMed Web of Science ®Google Scholar
• Walsh-Sukys MC. Persistent pulmonary hypertension of the newborn. The black box revisited. Clin. Perinatol.20(1), 127–143 (1993).
   PubMed Web of Science ®Google Scholar
• Abman SH. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn. Neonatology91(4), 283–290 (2007).
   PubMed Web of Science ®Google Scholar
• Dakshinamurti S. Pathophysiologic mechanisms of persistent pulmonary hypertension of the newborn. Pediatr. Pulmonol.39(6), 492–503 (2005).
   PubMed Web of Science ®Google Scholar
• Geggel RL, Reid LM. The structural basis of PPHN. Clin. Perinatol.11(3), 525–549 (1984).
   PubMed Web of Science ®Google Scholar
• Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol.54(Suppl. 1), S43–S54 (2009).
   PubMed Web of Science ®Google Scholar
• Clark RH, Huckaby JL, Kueser TJ et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J. Perinatol.23(4), 300–303 (2003).
   PubMedGoogle Scholar
• Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J. Pediatr.136(5), 611–617 (2000).
   PubMed Web of Science ®Google Scholar
• Konduri GG, Vohr B, Robertson C et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J. Pediatr.150(3), 235–240, e1 (2007).
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Badesch DB, Dempsey EC et al. Regulation of pulmonary vascular wall cell growth. Eur. Respir. Rev.3, 629–637 (1993).
   Google Scholar
• Cohen ED, Ihida-Stansbury K, Lu MM et al. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J. Clin. Invest.119(9), 2538–2549 (2009).
   PubMed Web of Science ®Google Scholar
• Shannon JM, Hyatt BA. Epithelial–mesenchymal interactions in the developing lung. Annu. Rev. Physiol.66, 625–645 (2004).
   PubMed Web of Science ®Google Scholar
• Cardoso WV, Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development133(9), 1611–1624 (2006).
   PubMed Web of Science ®Google Scholar
• Boyd JD. Development of the heart. In: Handbook of Physiology: A Critical, Comprehensive Presentation of Physiological Knowledge and Concepts. Section 2: Circulation. Hamilton WF, Dow P (Eds). Lippincott Williams & Wilkins, Washington, DC, USA, 2511–2544 (1965).
   Google Scholar
• Congdon ED. Transformation of the aortic arc system during the development of the human embryo. Carnegie Inst. Contrib. Embryology14, 47–110 (1922).
   Google Scholar
• Stenmark KR, Abman SH. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu. Rev. Physiol.67, 623–661 (2005).
   PubMed Web of Science ®Google Scholar
• deMello DE, Reid LM. Embryonic and early fetal development of human lung vasculature and its functional implications. Pediatr. Dev. Pathol.3(5), 439–449 (2000).
   PubMed Web of Science ®Google Scholar
• deMello DE, Sawyer D, Galvin N, Reid LM. Early fetal development of lung vasculature. Am. J. Respir. Cell. Mol. Biol.16(5), 568–581 (1997).
   PubMed Web of Science ®Google Scholar
• Galambos C, deMello DE. Molecular mechanisms of pulmonary vascular development. Pediatr. Dev. Pathol.10(1), 1–17 (2007).
   PubMed Web of Science ®Google Scholar
• Parera MC, van Dooren M, van Kempen M et al. Distal angiogenesis: a new concept for lung vascular morphogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol.288(1), L141–L149 (2005).
   PubMed Web of Science ®Google Scholar
• Schwarz MA, Caldwell L, Cafasso D, Zheng H. Emerging pulmonary vasculature lacks fate specification. Am. J. Physiol. Lung Cell. Mol. Physiol.296(1), L71–L81 (2009).
   Web of Science ®Google Scholar
• Eble JA, Niland S. The extracellular matrix of blood vessels. Curr. Pharm. Des.15(12), 1385–1400 (2009).
   PubMed Web of Science ®Google Scholar
• Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and regenerative medicine. J. Cell. Sci.121(Pt 3), 255–264 (2008).
   PubMed Web of Science ®Google Scholar
• Masumoto K, de Rooij JD, Suita S et al. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls. Histopathology48(5), 588–595 (2006).
   PubMed Web of Science ®Google Scholar
• Que J, Wilm B, Hasegawa H et al. Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development. Proc. Natl Acad. Sci. USA105(43), 16626–16630 (2008).
   PubMed Web of Science ®Google Scholar
• Morimoto M, Liu Z, Cheng HT et al. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J. Cell. Sci.123(Pt 2), 213–224 (2010).
   PubMed Web of Science ®Google Scholar
• Rawlins EL. The building blocks of mammalian lung development. Dev. Dyn.240(3), 463–476 (2011).
   PubMed Web of Science ®Google Scholar
• Reid LM. Lung growth in health and disease. Br. J. Dis. Chest78(2), 113–134 (1984).
   PubMedGoogle Scholar
• Reid LM. The pulmonary circulation: remodeling in growth and disease. The 1978 J. Burns Amberson lecture. Am. Rev. Respir. Dis.119(4), 531–546 (1979).
   PubMed Web of Science ®Google Scholar
• Hungerford JE, Little CD. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J. Vasc. Res.36(1), 2–27 (1999).
   PubMed Web of Science ®Google Scholar
• Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev.75(3), 487–517 (1995).
   PubMed Web of Science ®Google Scholar
• Maeda S, Suzuki S, Suzuki T et al. Analysis of intrapulmonary vessels and epithelial–endothelial interactions in the human developing lung. Lab. Invest.82(3), 293–301 (2002).
   PubMed Web of Science ®Google Scholar
• Schwarz MA, Zhang F, Gebb S, Starnes V, Warburton D. Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis. Mech. Dev.95(1–2), 123–132 (2000).
   PubMed Web of Science ®Google Scholar
• Groenman FA, Rutter M, Wang J et al. Effect of chemical stabilizers of hypoxia-inducible factors on early lung development. Am. J. Physiol. Lung Cell. Mol. Physiol.293(3), L557–L567 (2007).
   Google Scholar
• van Tuyl M, Liu J, Wang J et al. Role of oxygen and vascular development in epithelial branching morphogenesis of the developing mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol.288(1), L167–L178 (2005).
   Google Scholar
• Ferrara N, Carver-Moore K, Chen H et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature380(6573), 439–442 (1996).
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Ferreira V, Breier G et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature380(6573), 435–439 (1996).
   PubMed Web of Science ®Google Scholar
• Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature376(6535), 66–70 (1995).
   PubMed Web of Science ®Google Scholar
• Healy AM, Morgenthau L, Zhu X, Farber HW, Cardoso WV. VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung. Dev. Dyn.219(3), 341–352 (2000).
   PubMed Web of Science ®Google Scholar
• Voelkel NF, Vandivier RW, Tuder RM. Vascular endothelial growth factor in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol.290(2), L209–L221 (2006).
   PubMed Web of Science ®Google Scholar
• White AC, Lavine KJ, Ornitz DM. FGF9 and SHH regulate mesenchymal VEGFA expression and development of the pulmonary capillary network. Development134(20), 3743–3752 (2007).
   PubMed Web of Science ®Google Scholar
• Thebaud B, Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am. J. Respir. Crit. Care Med.175(10), 978–985 (2007).
   PubMed Web of Science ®Google Scholar
• Oettgen P. Transcriptional regulation of vascular development. Circ. Res.89(5), 380–388 (2001).
   PubMed Web of Science ®Google Scholar
• Harris AL. von Hippel–Lindau syndrome: target for anti-vascular endothelial growth factor (VEGF) receptor therapy. Oncologist5(Suppl. 1), 32–36 (2000).
   PubMedGoogle Scholar
• Krek W. VHL takes HIF’s breath away. Nat. Cell. Biol.2(7), E121–E123 (2000).
   Google Scholar
• von Tell D, Armulik A, Betsholtz C. Pericytes and vascular stability. Exp. Cell. Res.312(5), 623–629 (2006).
   PubMed Web of Science ®Google Scholar
• Donoghue L, Tyburski JG, Steffes CP, Wilson RF. Vascular endothelial growth factor modulates contractile response in microvascular lung pericytes. Am. J. Surg.191(3), 349–352 (2006).
   PubMed Web of Science ®Google Scholar
• Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial–mural cell signaling in vascular development and angiogenesis. Arterioscler. Thromb. Vasc. Biol.29(5), 630–638 (2009).
   PubMed Web of Science ®Google Scholar
• Ribatti D, Nico B, Crivellato E. Morphological and molecular aspects of physiological vascular morphogenesis. Angiogenesis12(2), 101–111 (2009).
   PubMed Web of Science ®Google Scholar
• Rossant J, Howard L. Signaling pathways in vascular development. Annu. Rev. Cell. Dev. Biol.18, 541–573 (2002).
   PubMed Web of Science ®Google Scholar
• Jain RK. Molecular regulation of vessel maturation. Nat. Med.9(6), 685–693 (2003).
   PubMed Web of Science ®Google Scholar
• Hislop AA, Pierce CM. Growth of the vascular tree. Paediatr. Respir. Rev.1(4), 321–327 (2000).
   PubMedGoogle Scholar
• Rudolph AM. Fetal and neonatal pulmonary circulation. Annu. Rev. Physiol.41, 383–395 (1979).
   PubMed Web of Science ®Google Scholar
• Haworth SG. Pathobiology of pulmonary hypertension in infants and children. Prog. Pediatr. Cardiol.12, 249–269 (2001).
   Google Scholar
• Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N. Engl. J. Med.351(14), 1425–1436 (2004).
   PubMed Web of Science ®Google Scholar
• Lincoln TM, Komalavilas P, Cornwell TL. Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension23(6 Pt 2), 1141–1147 (1994).
   PubMed Web of Science ®Google Scholar
• Ivy DD, Kinsella JP, Abman SH. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J. Clin. Invest.93(5), 2141–2148 (1994).
   PubMed Web of Science ®Google Scholar
• Levy M, Maurey C, Chailley-Heu B et al. Developmental changes in endothelial vasoactive and angiogenic growth factors in the human perinatal lung. Pediatr. Res.57(2), 248–253 (2004).
   PubMed Web of Science ®Google Scholar
• Tang JR, Markham NE, Lin YJ et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am. J. Physiol. Lung Cell. Mol. Physiol.287(2), L344–L351 (2004).
   PubMed Web of Science ®Google Scholar
• Abman SH, Chatfield BA, Rodman DM, Hall SL, McMurtry IF. Maturational changes in endothelium-derived relaxing factor activity of ovine pulmonary arteries in vitro. Am. J. Physiol.260(4 Pt 1), L280–L285 (1991).
   PubMed Web of Science ®Google Scholar
• Steinhorn RH, Morin FC 3rd, Gugino SF, Giese EC, Russell JA. Developmental differences in endothelium-dependent responses in isolated ovine pulmonary arteries and veins. Am. J. Physiol.264(6 Pt 2), H2162–H2167 (1993).
   PubMed Web of Science ®Google Scholar
• Shaul PW. Regulation of vasodilator synthesis during lung development. Early Hum. Dev.54(3), 271–294 (1999).
   PubMed Web of Science ®Google Scholar
• Fineman JR, Heymann MA, Soifer SJ. N omega-nitro-l-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am. J. Physiol.260(4 Pt 2), H1299–H1306 (1991).
   PubMed Web of Science ®Google Scholar
• Davidson D, Eldemerdash A. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated neonatal guinea pig lung. Pediatr. Res.29(6), 538–542 (1991).
   PubMed Web of Science ®Google Scholar
• Ivy DD, le Cras TD, Parker TA et al. Developmental changes in endothelin expression and activity in the ovine fetal lung. Am. J. Physiol. Lung Cell. Mol. Physiol.278(4), L785–L793 (2000).
   Google Scholar
• Tulloh RM, Hislop AA, Boels PJ, Deutsch J, Haworth SG. Chronic hypoxia inhibits postnatal maturation of porcine intrapulmonary artery relaxation. Am. J. Physiol.272(5 Pt 2), H2436–H2445 (1997).
   Google Scholar
• Badesch DB, Orton EC, Zapp LM et al. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am. J. Respir. Cell. Mol. Biol.1(6), 489–498 (1989).
   PubMed Web of Science ®Google Scholar
• Greenough A, Khetriwal B. Pulmonary hypertension in the newborn. Paediatr. Respir. Rev.6(2), 111–116 (2005).
   PubMedGoogle Scholar
• Steinhorn RH. Neonatal pulmonary hypertension. Pediatr. Crit. Care Med.11(Suppl. 2), S79–S84 (2010).
   PubMed Web of Science ®Google Scholar
• Morin FC 3rd. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr. Res.25(3), 245–250 (1989).
   PubMed Web of Science ®Google Scholar
• Abman SH, Accurso FJ. Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am. J. Physiol.257(2 Pt 2), H626–H634 (1989).
   Google Scholar
• Kay JM, Harris P, Heath D. Pulmonary hypertension produced in rats by ingestion of Crotalaria spectabilis seeds. Thorax22(2), 176–179 (1967).
   PubMed Web of Science ®Google Scholar
• Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst. Rev. (4), CD000399 (2006).
   Google Scholar
• Farrow KN, Fliman P, Steinhorn RH. The diseases treated with ECMO: focus on PPHN. Semin. Perinatol.29(1), 8–14 (2005).
   PubMed Web of Science ®Google Scholar
• Steinhorn RH, Kinsella JP, Pierce C et al. Intravenous sildenafil in the treatment of neonates with persistent pulmonary hypertension. J. Pediatr.155(6), 841–847 (2009).
   PubMed Web of Science ®Google Scholar
• Ahsman MJ, Witjes BC, Wildschut ED et al. Sildenafil exposure in neonates with pulmonary hypertension after administration via a nasogastric tube. Arch. Dis. Child Fetal Neonatal Ed.95(2), F109–F114 (2009).
   Google Scholar
• Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J. Pediatr.141(6), 830–832 (2002).
   PubMed Web of Science ®Google Scholar
• Ehlen M, Wiebe B. Iloprost in persistent pulmonary hypertension of the newborn. Cardiol. Young.13(4), 361–363 (2003).
   PubMed Web of Science ®Google Scholar
• De Luca D, Zecca E, Piastra M, Romagnoli C. Iloprost as ‘rescue’ therapy for pulmonary hypertension of the neonate. Paediatr. Anaesth.17(4), 394–395 (2007).
   PubMed Web of Science ®Google Scholar
• Goissen C, Ghyselen L, Tourneux P et al. Persistent pulmonary hypertension of the newborn with transposition of the great arteries: successful treatment with bosentan. Eur. J. Pediatr.167(4), 437–440 (2008).
   PubMed Web of Science ®Google Scholar
• van der Horst IW, Reiss I, Tibboel D. Therapeutic targets in neonatal pulmonary hypertension: linking pathophysiology to clinical medicine. Expert Rev. Respir. Med.2(1), 85–96 (2008).
   PubMedGoogle Scholar
• Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol. Ther.92(1), 1–20 (2001).
   PubMed Web of Science ®Google Scholar
• Stenmark KR, Fagan KA, Frid MG. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms. Circ. Res.99(7), 675–691 (2006).
   PubMed Web of Science ®Google Scholar
• Meyrick B, Reid L. Hypoxia-induced structural changes in the media and adventitia of the rat hilar pulmonary artery and their regression. Am. J. Pathol.100(1), 151–178 (1980).
   PubMed Web of Science ®Google Scholar
• Davie NJ, Crossno JT Jr, Frid MG et al. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells. Am. J. Physiol. Lung Cell. Mol. Physiol.286(4), L668–L678 (2004).
   PubMed Web of Science ®Google Scholar
• Frid MG, Brunetti JA, Burke DL et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am. J. Pathol.168(2), 659–669 (2006).
   PubMed Web of Science ®Google Scholar
• Hayashida K, Fujita J, Miyake Y et al. Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest127(5), 1793–1798 (2005).
   PubMed Web of Science ®Google Scholar
• Spees JL, Whitney MJ, Sullivan DE et al. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension. FASEB J.22(4), 1226–1236 (2008).
   PubMed Web of Science ®Google Scholar
• Jones R, Steudel W, White S, Jacobson M, Low R. Microvessel precursor smooth muscle cells express head-inserted smooth muscle myosin heavy chain (SM-B) isoform in hyperoxic pulmonary hypertension. Cell Tissue Res.295(3), 453–465 (1999).
   PubMed Web of Science ®Google Scholar
• Zengin E, Chalajour F, Gehling UM et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development133(8), 1543–1551 (2006).
   PubMed Web of Science ®Google Scholar
• Sobin SS, Tremer HM, Hardy JD, Chiodi HP. Changes in arteriole in acute and chronic hypoxic pulmonary hypertension and recovery in rat. J. Appl. Physiol.55(5), 1445–1455 (1983).
   PubMed Web of Science ®Google Scholar
• Sartore S, Chiavegato A, Faggin E et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: from innocent bystander to active participant. Circ. Res.89(12), 1111–1121 (2001).
   PubMed Web of Science ®Google Scholar
• Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol.293(1), L1–L8 (2007).
   PubMed Web of Science ®Google Scholar
• Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation109(2), 159–165 (2004).
   PubMed Web of Science ®Google Scholar
• Abman SH. Abnormal vasoreactivity in the pathophysiology of persistent pulmonary hypertension of the newborn. Pediatr. Rev.20(11), e103–e109 (1999).
   Google Scholar
• Manchester D, Margolis HS, Sheldon RE. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am. J. Obstet. Gynecol.126(4), 467–469 (1976).
   PubMed Web of Science ®Google Scholar
• Chambers CD, Hernandez-Diaz S, Van Marter LJ et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N. Engl. J. Med.354(6), 579–587 (2006).
   PubMed Web of Science ®Google Scholar
• Kallen B, Olausson PO. Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol. Drug Saf.17(8), 801–806 (2008).
   PubMed Web of Science ®Google Scholar
• Murphy JD, Rabinovitch M, Goldstein JD, Reid LM. The structural basis of persistent pulmonary hypertension of the newborn infant. J. Pediatr.98(6), 962–967 (1981).
   PubMed Web of Science ®Google Scholar
• Haworth SG. Pulmonary vascular remodeling in neonatal pulmonary hypertension. State of the art. Chest93(Suppl. 3), S133–S138 (1988).
   Google Scholar
• Villanueva ME, Zaher FM, Svinarich DM, Konduri GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr. Res.44(3), 338–343 (1998).
   PubMed Web of Science ®Google Scholar
• Pearson DL, Dawling S, Walsh WF et al. Neonatal pulmonary hypertension–urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N. Engl. J. Med.344(24), 1832–1838 (2001).
   PubMed Web of Science ®Google Scholar
• Kumar P, Kazzi NJ, Shankaran S. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am. J. Perinatol.13(6), 335–341 (1996).
   PubMed Web of Science ®Google Scholar
• Rosenberg AA, Kennaugh J, Koppenhafer SL et al. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J. Pediatr.123(1), 109–114 (1993).
   PubMed Web of Science ®Google Scholar
• Lassus P, Turanlahti M, Heikkila P et al. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am. J. Respir. Crit. Care Med.164(10 Pt 1), 1981–1987 (2001).
   PubMed Web of Science ®Google Scholar
• Klaassens M, de Klein A, Tibboel D. The etiology of congenital diaphragmatic hernia: still largely unknown? Eur. J. Med. Genet.52(5), 281–286 (2009).
   Google Scholar
• Beurskens LW, Tibboel D, Lindemans J et al. Retinol status of newborn infants is associated with congenital diaphragmatic hernia. Pediatrics13(8), 547–549 (2010).
   Google Scholar
• Rottier R, Tibboel D. Fetal lung and diaphragm development in congenital diaphragmatic hernia. Semin. Perinatol.29(2), 86–93 (2005).
   PubMed Web of Science ®Google Scholar
• Boucherat O, Franco-Montoya ML, Delacourt C et al. Defective angiogenesis in hypoplastic human fetal lungs correlates with nitric oxide synthase deficiency that occurs despite enhanced angiopoietin-2 and VEGF. Am. J. Physiol. Lung Cell. Mol. Physiol.298(6), L849–L856 (2010).
   PubMed Web of Science ®Google Scholar
• Taira Y, Yamataka T, Miyazaki E, Puri P. Comparison of the pulmonary vasculature in newborns and stillborns with congenital diaphragmatic hernia. Pediatr. Surg. Int.14(1–2), 30–35 (1998).
   PubMed Web of Science ®Google Scholar
• Shehata SM, Tibboel D, Sharma HS, Mooi WJ. Impaired structural remodelling of pulmonary arteries in newborns with congenital diaphragmatic hernia: a histological study of 29 cases. J. Pathol.189(1), 112–118 (1999).
   PubMed Web of Science ®Google Scholar
• Yamataka T, Puri P. Pulmonary artery structural changes in pulmonary hypertension complicating congenital diaphragmatic hernia. J. Pediatr. Surg.32(3), 387–390 (1997).
   PubMed Web of Science ®Google Scholar
• Shehata SM, Sharma HS, van der Staak FH et al. Remodeling of pulmonary arteries in human congenital diaphragmatic hernia with or without extracorporeal membrane oxygenation. J. Pediatr. Surg.35(2), 208–215 (2000).
   PubMed Web of Science ®Google Scholar
• Unger S, Copland I, Tibboel D, Post M. Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia. Am. J. Pathol.162(2), 547–555 (2003).
   PubMed Web of Science ®Google Scholar
• de Rooij JD, Hosgor M, Ijzendoorn Y et al. Expression of angiogenesis-related factors in lungs of patients with congenital diaphragmatic hernia and pulmonary hypoplasia of other causes. Pediatr. Dev. Pathol.7(5), 468–477 (2004).
   PubMed Web of Science ®Google Scholar
• de Lagausie P, de Buys-Roessingh A, Ferkdadji L et al. Endothelin receptor expression in human lungs of newborns with congenital diaphragmatic hernia. J. Pathol.205(1), 112–118 (2005).
   PubMed Web of Science ®Google Scholar
• Keller RL, Tacy TA, Hendricks-Munoz K et al. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am. J. Respir. Crit. Care Med.182(4), 555–561 (2010).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Puri P. Plasma endothelin levels in congenital diaphragmatic hernia. J. Pediatr. Surg.29(9), 1258–1261 (1994).
   PubMed Web of Science ®Google Scholar
• Buchta RM, Viseskul C, Gilbert EF, Sarto GE, Opitz JM. Familial bilateral renal agenesis and hereditary renal adysplasia. Z Kinderheilkd.115(2), 111–129 (1973).
   PubMedGoogle Scholar
• Whitehouse W, Mountrose U. Renal agenesis in nontwin siblings. Am. J. Obstet Gynecol.116(6), 880–882 (1973).
   PubMed Web of Science ®Google Scholar
• Cain DR, Griggs D, Lackey DA, Kagan BM. Familial renal agenesis and total dysplasia. Am. J. Dis. Child.128(3), 377–380 (1974).
   PubMedGoogle Scholar
• Hack M, Jaffe J, Blankstein J, Goodman RM, Brish M. Familial aggregation in bilateral renal agenesis. Clin. Genet.5(2), 173–177 (1974).
   PubMed Web of Science ®Google Scholar
• Alcorn D, Adamson TM, Lambert TF et al. Morphological effects of chronic tracheal ligation and drainage in the fetal lamb lung. J. Anat.123(Pt 3), 649–660 (1977).
   PubMed Web of Science ®Google Scholar
• Strang LB. Growth and development of the lung: fetal and postnatal. Annu. Rev. Physiol.39, 253–276 (1977).
   PubMed Web of Science ®Google Scholar
• Clemmons J. Embryonic renal injury: a possible factor in fetal malnutrition (abstract). Pediatr. Res.11, 404 (1977).
   Google Scholar
• Perlman M, Williams J, Hirsch M. Neonatal pulmonary hypoplasia after prolonged leakage of amniotic fluid. Arch. Dis. Child.51(5), 349–353 (1976).
   PubMed Web of Science ®Google Scholar
• Tibboel D, Gaillard JL, Spritzer R, Wallenburg HC. Pulmonary hypoplasia secondary to oligohydramnios with very premature rupture of fetal membranes. Eur. J. Pediatr.149(7), 496–499 (1990).
   PubMed Web of Science ®Google Scholar
• Blott M, Greenough A, Nicolaides KH. Fetal breathing movements in pregnancies complicated by premature membrane rupture in the second trimester. Early Hum. Dev.21(1), 41–48 (1990).
   PubMed Web of Science ®Google Scholar
• Wigglesworth JS, Desai R, Guerrini P. Fetal lung hypoplasia: biochemical and structural variations and their possible significance. Arch. Dis. Child.56(8), 606–615 (1981).
   PubMed Web of Science ®Google Scholar
• Hislop A, Hey E, Reid L. The lungs in congenital bilateral renal agenesis and dysplasia. Arch. Dis. Child.54(1), 32–38 (1979).
   PubMed Web of Science ®Google Scholar
• Fanaroff AA. Meconium aspiration syndrome: historical aspects. J. Perinatol.28(Suppl. 3), S3–S7 (2008).
   Google Scholar
• Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr. Clin. North Am.45(3), 511–529 (1998).
   PubMed Web of Science ®Google Scholar
• Dargaville PA, Copnell B. Australian and New Zealand Neonatal N, the epidemiology of meconium aspiration syndrome: incidence, risk factors, therapies, and outcome. Pediatrics117(5), 1712–1721 (2006).
   PubMed Web of Science ®Google Scholar
• Murphy JD, Vawter GF, Reid LM. Pulmonary vascular disease in fatal meconium aspiration. J. Pediatr.104(5), 758–762 (1984).
   PubMed Web of Science ®Google Scholar
• Erzurum S, Rounds SI, Stevens T et al. Strategic plan for lung vascular research: an NHLBI-ORDR workshop report. Am. J. Respir. Crit. Care Med.182(12), 1554–1562 (2010).
   PubMed Web of Science ®Google Scholar
• Simonneau G, Galie N, Rubin LJ et al. Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol.43(12 Suppl. S), S5–S12 (2004).
   PubMed Web of Science ®Google Scholar
• Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001–2006. Heart95(4), 312–317 (2009).
   PubMed Web of Science ®Google Scholar